Clinical Trial: Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Platelet Function and Reactivity Tests
Study Type: INTERVENTIONAL
Official Title: Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs: an Interventional Study
Brief Summary:
This study will identify the potential benefits of regulating platelet activation with sotagliflozin compared to other FDA-approved drugs known to limit platelet activation.
Read more